It looks like the Biotech industry is continuing to grow in the Triangle.
Apparently, Roche, the Swiss drug maker that produces Tamiflu is eyeing Holly Springs for a $750 million plant.
This would be in addition to the $300 million Merck plant being built in Durham and the $190 million expansion to GlaxoSmithLine in Zebulon.
Triangle Business Journal Article
Wednesday, November 16, 2005
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment